Nephros (NEPH) Payables (2010 - 2026)

Nephros' Payables history runs 17 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• On a quarterly basis, Payables rose 162.66% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 162.66% increase from a year earlier, with the FY2025 full-year figure at $914000.0, up 40.83% from the prior year.
• Payables rose to $1.5 million in Q1 2026 per NEPH's latest filing, from $914000.0 in the prior quarter.
• Across five years, Payables topped out at $1.5 million in Q1 2026 and bottomed at $302000.0 in Q2 2023.
• The 5-year median for Payables is $805000.0 (2023), against an average of $844000.0.
• Across the five-year window, Payables tumbled 78.6% in 2023 and jumped 283.77% in 2024, its largest moves.
• Year by year, Payables stood at $740000.0 in 2022, then advanced by 17.97% to $873000.0 in 2023, then retreated by 25.66% to $649000.0 in 2024, then soared by 40.83% to $914000.0 in 2025, then jumped by 60.07% to $1.5 million in 2026.
• Per Business Quant, the three latest NEPH Payables figures stand at $1.5 million (Q1 2026), $914000.0 (Q4 2025), and $936000.0 (Q3 2025).